MarketPeel
Insider Trading Intelligence
BO

Brendan P. O'grady

TEVA
EVP, NORTH AMERICA COMMERCIAL · TEVA PHARMACEUTICAL INDUSTRIES LTD · CIK 0001726533
FILING MIX · LIFETIME43%/57%
BUYS
16
SELLS
21
TOTAL VALUE
$1.55M
COMPANIES
2
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
442,650
AVG SELL PX
$8.35
TRADE KIND
SHOWING 37 / 37
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
13 backtested trades · 8 horizons · 1 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Brendan P. O'grady, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d13+53.85%-0.27%+0.34%-0.61%-0.15%
14d13+30.77%+0.95%+0.18%+0.77%+2.99%
30d13+38.46%+1.42%+1.08%+0.33%+1.81%
60d13+69.23%-0.88%+5.14%-6.02%-9.21%
90d13+61.54%+1.11%+7.57%-6.46%-11.67%
180d13+84.62%-11.55%+16.24%-27.79%-30.71%
1y13+76.92%-15.79%+20.06%-35.85%-40.80%
2y13(1 pending)+91.67%-11.97%+19.94%-31.91%-16.40%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TEVA · 109,315 shares · as of Mar 5, 2021
027,32954,65881,986109,3152021SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
FLOW · 16 buys / 21 sellsCOVERAGE · 22 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ASRT
ASSERTIO HOLDINGS, INC.
SALE
CEO
49,416$0.66$32.8K128,955.462May 31, 2025Jun 3, 2025View →
ASRT
ASSERTIO HOLDINGS, INC.
PURCHASE
CEO
166,665178,371.462May 31, 2025Jun 3, 2025View →
ASRT
ASSERTIO HOLDINGS, INC.
SALE
CEO
166,665333,335May 31, 2025Jun 3, 2025View →
ASRT
ASSERTIO HOLDINGS, INC.
PURCHASEGRANT
Stock grant
755,525755,525Feb 18, 2025Feb 20, 2025View →
ASRT
ASSERTIO HOLDINGS, INC.
PURCHASEGRANT
Stock grant
500,000500,000Feb 18, 2025Feb 20, 2025View →
ASRT
ASSERTIO HOLDINGS, INC.
PURCHASE
CEO
11,706.462$0.85$10.0K11,706.462Nov 14, 2024Nov 15, 2024View →
ASRT
ASSERTIO HOLDINGS, INC.
PURCHASEGRANT
Stock grant
1,800,0001,800,000May 31, 2024Jun 4, 2024View →
ASRT
ASSERTIO HOLDINGS, INC.
PURCHASEGRANT
Stock grant
500,000500,000May 31, 2024Jun 4, 2024View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, North America Commercial
11,436$10.54$120.6K14,868.486Mar 5, 2021Mar 8, 2021View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
109,315109,315Mar 5, 2021Mar 8, 2021View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, North America Commercial
18,90537,811Mar 4, 2021Mar 8, 2021View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
EVP, North America Commercial
18,90533,773.486Mar 4, 2021Mar 8, 2021View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, North America Commercial
7,469$10.57$78.9K26,304.486Mar 4, 2021Mar 8, 2021View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, North America Commercial
703$10.80$7.6K14,868.486Mar 4, 2021Mar 8, 2021View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
EVP, North America Commercial
1,16616,034.486Mar 3, 2021Mar 4, 2021View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, North America Commercial
1,1660Mar 3, 2021Mar 4, 2021View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, North America Commercial
463$10.86$5.0K15,571.486Mar 3, 2021Mar 4, 2021View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, North America Commercial
15,085$10.85$163.6K14,868.486Mar 2, 2021Mar 4, 2021View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, North America Commercial
63,278$10.93$691.4K29,953.486Mar 1, 2021Mar 2, 2021View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, North America Commercial
9,849$10.83$106.7K93,231.486Mar 1, 2021Mar 2, 2021View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, North America Commercial
24,93474,805Feb 28, 2021Mar 2, 2021View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
EVP, North America Commercial
24,934103,080.486Feb 28, 2021Mar 2, 2021View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
67,85298,840.486Feb 9, 2021Feb 11, 2021View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
EVP, North America Commercial
16,12030,988.486Feb 9, 2021Feb 11, 2021View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, North America Commercial
16,12016,121Feb 9, 2021Feb 11, 2021View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, North America Commercial
3,974$12.69$50.4K94,866.486Feb 9, 2021Feb 11, 2021View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, North America Commercial
16,720$12.69$212.3K78,146.486Feb 9, 2021Feb 11, 2021View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, North America Commercial
470$7.16$3.4K14,868.486Mar 17, 2020Mar 19, 2020View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, North America Commercial
1,1790Mar 17, 2020Mar 19, 2020View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
EVP, North America Commercial
1,17915,338.486Mar 17, 2020Mar 19, 2020View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, North America Commercial
463$11.37$5.3K14,159.486Mar 3, 2020Mar 5, 2020View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, North America Commercial
1,1661,166Mar 3, 2020Mar 5, 2020View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
EVP, North America Commercial
1,16614,622.486Mar 3, 2020Mar 5, 2020View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
99,73999,739Feb 28, 2020Mar 3, 2020View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, North America Commercial
4,799$12.27$58.9K13,456.486Feb 10, 2020Feb 11, 2020View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, North America Commercial
16,12032,241Feb 9, 2020Feb 11, 2020View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
EVP, North America Commercial
16,12018,255.486Feb 9, 2020Feb 11, 2020View →
Other insiders · TEVA
Loading peer insiders…
About this filer
CIK 0001726533
ROLE
EVP, North America Commercial
PRIMARY
TEVA
COMPANIES
2
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001726533DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback